As highlighted, there is an increasing trend to assess the feasibility of broadening the indications for active surveillance to a larger pool of patients, which further underscores the need to incorporate patients’ values and preferences into the management of low-risk thyroid cancer [ 2 , 3 ].
← all excerpts
Study Protocol of Expanded Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma (MAeSTro-EXP) (Endocrinol Metab 2025;40:236-46, Jae Hoon Moon et al.).
1
—
—